ERK/BCL-2 Pathway in the Resistance of Pancreatic Cancer to Anoikis von Galante, Joseph M., M.D, Mortenson, Melinda M., M.D, Bowles, Tawnya L., M.D, Virudachalam, Subbulakshmi, M.S, Bold, Richard J., M.D

Volltext

Current diagnosis and management of unusual pancreatic tumors von Mortenson, Melinda M., M.D, Katz, Matthew H.G., M.D, Tamm, Eric P., M.D, Bhutani, Manoop S., M.D, Wang, Huamin, M.D., Ph.D, Evans, Douglas B., M.D, Fleming, Jason B., M.D

Volltext

BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer von Mortenson, Melinda M., Galante, Joseph G., Gilad, Oren, Schlieman, Michael G., Virudachalam, Subbulakshmi, Kung, Hsing-Jien, Bold, Richard J.

Volltext

Implementation of Intraoperative Ultrasound Localization for Breast-Conserving Surgery in a Large, Integrated Health Care System is Feasible and Effective von Chakedis, Jeffery M., Tang, Annie, Kuehner, Gillian E., Vuong, Brooke, Lyon, Liisa L., Romero, Lucinda A., Raber, Benjamin M., Mortenson, Melinda M., Shim, Veronica C., Datrice-Hill, Nicole M., McEvoy, Jennifer R., Arasu, Vignesh A., Wisner, Dorota J., Chang, Sharon B.

Volltext

Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT0050... von Mortenson, Melinda M, Xing, Yan, Weaver, Storm, Lee, Jeffrey E, Gershenwald, Jeffrey E, Lucci, Anthony, Mansfield, Paul F, Ross, Merrick I, Cormier, Janice N

Volltext

ASO Visual Abstract: Implementation of Intraoperative Ultrasound Localization for Breast-Conserving Surgery in a Large, Integrated Health Care System is Feasible and Effective von Chakedis, Jeffery M., Tang, Annie, Kuehner, Gillian E., Vuong, Brooke, Lyon, Liisa L., Romero, Lucinda A., Raber, Benjamin M., Mortenson, Melinda M., Shim, Veronica C., Hill, Nicole M. Datrice, McEvoy, Jennifer R., Arasu, Vignesh A., Wisner, Dorota J., Chang, Sharon B.

Volltext

Comparison of Two Methods of Future Liver Remnant Volume Measurement von Chun, Yun Shin, Ribero, Dario, Abdalla, Eddie K., Madoff, David C., Mortenson, Melinda M., Wei, Steven H., Vauthey, Jean-Nicolas

Volltext

Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib von FAHY, Bridget N, SCHLIEMAN, Michael G, MORTENSON, Melinda M, VIRUDACHALAM, Subbulakshmi, BOLD, Richard J

Volltext

Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line von MORTENSON, Melinda M, SCHLIEMAN, Michael G, VIRUDACHALAM, Subbulakshmi, BOLD, Richard J

Volltext

Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer von Mortenson, Melinda M., Schlieman, Michael G., Virudachalam, Subbulakshmi, Lara, Primo N., Gandara, David G., Davies, Angela M., Bold, Richard J.

Volltext

An analysis of cost and clinical outcome in palliation for advanced pancreatic cancer von Mortenson, Melinda M., Ho, Hung S., Bold, Richard J.

Volltext

Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy von Lara, Primo N, Davies, Angela M, Mack, Philip C, Mortenson, Melinda M, Bold, Richard J, Gumerlock, Paul H, Gandara, David R

Volltext

Immediate Breast Reconstruction After Mastectomy Increases Wound Complications: However, Initiation of Adjuvant Chemotherapy Is Not Delayed von Mortenson, Melinda M, Schneider, Philip D, Khatri, Vijay P, Stevenson, Thomas R, Whetzel, Thomas P, Sommerhaug, Eiler J, Goodnight, Jr, James E, Bold, Richard J

Volltext

Lymph node sampling for rectal cancer: How much is enough? von Mortenson, Melinda M., Chang, George J.

Volltext

Targeting BCL-2 overexpression in various human malignancies through NF-[kappa]B inhibition by the proteasome inhibitor bortezomib von Fahy, Bridget N, Schlieman, Michael G, Mortenson, Melinda M, Subbulakshmi Virudachalam, Bold, Richard J

Volltext

Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib von Fahy, Bridget N, Schlieman, Michael G, Mortenson, Melinda M, Virudachalam, Subbulakshmi, Bold, Richard J

Volltext

Proteasome inhibition with PS-341 (Bortezomib) in lung cancer therapy: Current Perspectives and Novel Strategies in the Treatment of Patients With Lung Cancer von LARA, Primo N, DAVIES, Angela M, MACK, Philip C, MORTENSON, Melinda M, BOLD, Richard J, GUMERLOCK, Paul H, GANDARA, David R

Volltext

Pancreatic Carcinoma von Mortenson, Melinda M., Kennamer, Debra L., Tamm, Eric P., Wang, Huamin, Evans, Douglas B.

Volltext

2014 APSA Teaching and Learning Conference and Track Summaries von Mealy, Kimberly A.

Volltext